Eric Buatois
CIK 1362314 · last filed 2016-10-24
Eric Buatois is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider sold $9.4M of MRNS on Oct 24, 2016. Across all open-market trades the lifetime net is −$31.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.06M
2
2
-$31.09M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | 10%+ Owner | 3,868 | $0.55 | $2.1K | -$9.38M | 1 | 2016-10-24 |
| AMRN | 10%+ Owner | 446,914 | $13.55 | $6.06M | -$21.71M | 1 | 2011-03-28 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-24 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Sell (S) | −6,756,147 | -$9.38M | EDGAR |
| 2011-03-28 | AMRN | Sell (S) | −2,875,500 | -$21.71M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.